Login / Signup

Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.

Maria Elvira BalcellsLuis RojasNicole Le CorreConstanza Martínez-ValdebenitoMaria Elena CeballosMarcela FerrésMayling ChangCecilia VizcayaSebastián MondacaAlvaro HueteRicardo CastroMauricio Sarmiento MaldonadoLuis VillarroelAlejandra PizarroPatricio RossJaime SantanderBárbara LaraMarcela FerradaSergio Vargas-SalasCarolina Beltrán-PavezRicardo Soto-RifoFernando Valiente-EcheverríaChristian CaglevicMauricio MahaveCarolina SelmanRaimundo GazitúaJosé Luis BrionesFranz Villarroel-EspindolaCarlos BalmacedaManuel Antonio EspinozaJaime PereiraBruno Nervi
Published in: PLoS medicine (2021)
NCT04375098.
Keyphrases
  • phase ii
  • sars cov
  • clinical trial
  • open label
  • respiratory syndrome coronavirus
  • double blind
  • placebo controlled
  • coronavirus disease
  • study protocol